Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Regeneron Pharmaceuticals hired Dr. David Weinreich as senior vice president, late-stage clinical development and medical affairs. Most recently, he worked at Bayer Pharmaceuticals, where he was senior vice president and head of global development for specialty medicine. He has also worked at Amgen and Gene Logic.

Astellas named Martin Golden as senior vice president and head of marketing strategy;


Astellas promoted Frank Hudson to senior vice president and head of budget & control;

Astellas promoted Walt Johnson to senior vice president, urology and hospital;


Astellas promoted Mark Reisenauer to senior vice president, oncology;

Astellas promoted Kenton Stewart to senior vice president, hospital and health systems;

Astellas promoted Catherine Wertjes to head of ethics and compliance;

Valeant Pharmaceuticals said that Deb Jorn resigned as executive VP, company group chairman;

Valeant Pharmaceuticals named Eric Abramson as general manager of the US dermatology business;

Valeant Pharmaceuticals said Ari Kellen, executive VP and company group chairman, will oversee the gastrointestinal business;

Merck is adding Mathai Mammen in a senior role in discovery research;

Aeras hired Danilo Casimiro as chief scientific officer;

Prime Therapeutics hired Dr. Jonathan Gavras as chief medical officer;

Arvinas hired Dr. Angela Shen as chief medical officer;

Spero Therapeutics hired Cristina Larkin as chief commercial officer;

BioNJ hired Rebecca Perkins as vice president, government affairs;

3SBio hired Kevin Xiao Weihong as chief operating officer;

IntelGenx hired Dana Matzen as vice president, business development;

Arsanis hired Michael Gray as chief financial officer and chief business officer;

Cypralis hired Michael Peel as chief scientific officer;

Regenxbio hired Faraz Ali as chief business officer;

Huya Bioscience International hired Dr. Akira Miyazato as VP, head of clinical R&D in Japan.